Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Assets Average (2016 - 2021)

Phio Pharmaceuticals' Assets Average history spans 10 years, with the latest figure at $29.8 million for Q3 2021.

  • For Q3 2021, Assets Average rose 55.01% year-over-year to $29.8 million; the TTM value through Sep 2021 reached $29.8 million, up 55.01%, while the annual FY2020 figure was $11.9 million, 1.79% up from the prior year.
  • Assets Average reached $29.8 million in Q3 2021 per PHIO's latest filing, down from $32.8 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $32.8 million in Q2 2021 to a low of $3.6 million in Q1 2018.
  • Average Assets Average over 5 years is $13.5 million, with a median of $11.2 million recorded in 2020.
  • Peak YoY movement for Assets Average: plummeted 69.94% in 2018, then soared 303.45% in 2019.
  • A 5-year view of Assets Average shows it stood at $5.1 million in 2017, then surged by 88.84% to $9.6 million in 2018, then fell by 5.3% to $9.1 million in 2019, then surged by 87.54% to $17.0 million in 2020, then skyrocketed by 75.41% to $29.8 million in 2021.
  • Per Business Quant, the three most recent readings for PHIO's Assets Average are $29.8 million (Q3 2021), $32.8 million (Q2 2021), and $24.8 million (Q1 2021).